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Abstract
Acne vulgaris is a common skin condition, one that is associated with significant psychological
disability. The psychological impairments in acne include higher rates of depression, anxiety, anger
and suicidal thoughts. Despite a paucity of clinical research, patients with skin conditions and/or
mental health disorders are frequent consumers of dietary supplements. An overlap may exist
between nutrients that potentially have both anti-acne and mood regulating properties; examples
include omega-3 fatty acids from fish oil, chromium, zinc and selenium. Here we report on five
cases of acne treated with eicosapentaenoic acid and antioxidant nutrients. Self-administration of
these nutrients may have improved inflammatory acne lesions and global aspects of well-being; the
observations suggest a need for controlled trials.
Background
Acne vulgaris is a common disease in developed nations,
one that has increased in frequency in the last half cen-
tury, particularly among adult women [1]. While the expe-
rience of acne may not be life-threatening per se, it does
carry with it significant psychological disability. Indeed
the psychological sequela of acne includes higher rates of
clinical depression and anxiety, anger, suicidal thoughts
and even suicide itself [2-6]. Evaluations have determined
that patients with acne have a more significant impair-
ment of mental health than many other chronic medical
conditions, including epilepsy and diabetes [7]. Self-
esteem issues are likely the driving force behind higher
rates of unemployment in acne, however there is also an
existing bias whereby patients with acne are more likely to
be passed over by prospective employers [8].
The precise mechanisms of the acne process are not com-
pletely understood, however it is known to be character-
ized by sebum overproduction, follicular
hyperkeratinization, oxidative stress and inflammation.
Androgens, microbes and other pathogenetic influences
are also at work in the development of acne [9]. Since
inflammation is one of the earliest events to occur in the
acne process, the influence of inflammatory mediators
and subsequent free radical generation has become a
major focus of experimental and clinical research [10].
Speculation that dietary factors can influence acne has
been a matter of debate for decades, and emerging
research is certainly suggesting that diet may indeed be an
important factor, particularly in mediating the inflamma-
tion and oxidative stress of the acne process [11-13]. Hints
that omega-3 fatty acids might positively influence acne
originate from older epidemiological studies which show
that communities that maintain a traditional diet high in
omega-3 fatty acids have low rates of acne [14]. One study
in over 1000 teenagers from North Carolina found that
each of the primary signs of acne – comedones, papules,
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pustules, acne cysts and oily skin – were significantly
lower in in those consuming the greatest amounts of fish
and seafood [15]. A separate investigation showed that
patients actually with acne are more likely to be infre-
quent consumers of dietary fish and seafood [16]. More
recently, investigators have outlined mechanisms
whereby fish oil may be effective in reducing inflamma-
tory acne. The inflammatory chemical leukotriene B4
(LTB4) is now know to up-regulate sebum production,
and synthetic inhibition of LTB4, in the form of the drug
zileuton, leads to significant improvement in acne
[17,18]. Eicosapentaenoic acid (EPA) from fish oil, and
gamma-linolenic acid (GLA) from borage oil, have been
reported to inhibit the conversion of arachidonic acid into
LTB4 to the same degree as the LTB4-inhibiting acne drug
candidate zileuton [19]. Sophisticated studies have
recently demonstrated that each pilosebaceous unit has
the machinery in place to manufacture inflammatory
chemicals, including LTB4, with the raw materials sup-
plied from the breakdown products of dietary fats [20].
Fish oil, and EPA in particular, has a wealth of research to
support its ability to inhibit LTB4 production [21], yet to
date, no investigators have reported on the clinical utility
of fish oil for acne.
A number of emerging studies have also shown that acne
patients may be under increased local and systemic oxida-
tive stress, and the lowered blood levels of various antioxi-
dant and anti-inflammatory nutrients might be a
reflection of the increased demand in acne [22-24]. For
example, lower levels of vitamins A and E among 200 age-
matched acne patients vs. controls was recently found to
be associated with the severity of acne [25]. Furthermore,
since the selenium-dependent glutathione peroxidase
enzyme activity is low in acne patients, it has been theo-
rized that selenium would be of value. Indeed, low levels
of blood selenium have been documented in acne
patients, and one study examined the effect of selenium
(400 mcg) and vitamin E (20 mg) daily for 12 weeks in
acne. The combination led to improvements, especially in
those with low baseline glutathione peroxidase activity
[26,27]. The epigallocatechin-3-gallate (EGCG) polyphe-
nol from green tea has also been suggested to be helpful
in acne due to its well documented anti-inflammatory
and antioxidant activity. In addition, reports suggests
EGCG may also influence hormonal aspects of acne since
it is known to possess 5-α-reductase inhibiting properties
when applied topically [28]. Other botanical remedies
which have antioxidant and anti-inflammatory activity,
such as turmeric, have a long history of use in skin disor-
ders such as acne [29].
Various studies over the last three decades have shown
that zinc levels are lower in acne patients than controls,
and that oral and topical combination zinc may be of
therapeutic value [30-32]. There have also been hints in
the literature that insulin and blood sugar abnormalities
may be involved in the promotion of acne. The therapeu-
tic value of tolbutamide and other oral sulphonylureas in
acne has resulted in some scientists referring to acne as
diabetes of the skin [33]. Epidemiological studies suggest
that traditional diets with a low glycemic load are protec-
tive against acne [34] and one open label trial showed that
400 mcg of chromium improves acne [35]. Clinical inter-
vention studies show that a diet with an overall low glyc-
emic load, more dietary fiber, more fish and seafood is
helpful in acne. Results show an average 22 less acne
lesions in those who adhere to such a diet [11,12].
On the one hand there are certainly hints that marine lip-
ids, minerals and phytochemicals might have potential to
reduce inflammatory acne lesions, and on the other, it is
almost difficult not to notice that these are the very same
nutrients that have been shown to influence mental out-
look, depressive symptoms and anxiety. Omega-3 fatty
acids [36], zinc [37], selenium [38], chromium [39], and
even phytochemicals such as those found in green tea
[40], have been shown to improve mood and decrease
anxiety in various clinical and experimental studies. We,
and others [41], have wondered if such dietary nutrients,
or combinations thereof, might influence inflammatory
acne and perhaps more importantly, the mental outlook
of users with acne. Clinical studies utilizing dietary
changes or specific nutrient interventions in acne have not
evaluated aspects of mood or mental health as an out-
come.
Brief report
Given this background on the dietary nutrients that may
mediate both the acne process and mental well-being, we
decided to track users of an omega-3-based dietary supple-
ment purported to help with acne. The supplement (per-
fect skin, Genuine Health Inc, Toronto, Canada), is readily
available through internet and retail outlets, it is not,
however, sold, promoted or endorsed in our clinic. Each
capsule of this supplement contains 250 mg of EPA (from
sardines and anchovies), 3.75 mg of zinc gluconate, 50
mcg of selenium, 50 mcg of chromium and 50 mg of
EGCG from green tea extract. The total daily intake is pro-
vided in table 1.
Patients with acne and other skin conditions frequently
inquire about the utility of various dietary supplements.
Table 1: Daily intake from omega-3, poly-nutrient supplement
Eicosapentaenoic Acid 1000 mg
EGCG 200 mg
Zinc Gluconate 15 mg
Selenium 200 mcg
Chromium 200 mcgLipids in Health and Disease 2008, 7:36 http://www.lipidworld.com/content/7/1/36
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Research shows that individuals with skin conditions
and/or mental health disorders are among the highest
consumers of dietary supplements [42-44]. The clinical
value of such supplements remains largely uninvestigated.
Over the course of one year in our high-volume clinic, we
identified and followed 5 subjects with mild to moderate
acne vulgaris who initiated and consistently used the
omega-3-nutrient combination at the package-suggested
four capsules per day, for at least two months. The cap-
sules were self-administered by the patients, and those
who agreed to be followed signed informed consent con-
cerning our interest and evaluation of outcome as case
reports. In the three males and two females (aged 18–23)
who disclosed that they would be initiating the dietary
supplement, we performed a total comedonal lesion and
inflammatory papule count based on the acne grading
system established by Allen and Smith [45]. We also had
the patients complete the Arizona Integrative Outcomes
Scale (AIOS). The AIOS is a validated instrument designed
to detect changes in global aspects of well-being, includ-
ing mental, emotional and social well-being over time. It
is a broad assessment, based simply on a 10 cm visual ana-
log scale (VAS) which is used to provide a single numeri-
cal value to these constructs of well-being [46]. During the
2-month time period of self-administration of the dietary
supplement, the 5 users reported that they did not alter
dietary habits or overall lifestyle, did not take any other
dietary supplements, and other than a mild facial
cleanser, did not initiate any oral or topical anti-acne
interventions.
Discussion
The self-administration of an omega-3 fish oil-based
nutrient combination for two months did appear to have
some influence on the acne process, and perhaps more
importantly, on mental outlook. Specifically, four of the
individuals had a reduction in total lesion count, with a
range of 11 to 41 less lesions after 2 months. The average
total lesion count among the group dropped from 62.8 to
40.4. It was in the area of inflammatory lesions where the
intervention seemed to make a more significant differ-
ence. This reduction of marked inflammation and redness
of lesions is apparent in the photographic evidence of fig-
ures 1, 2. Remarkably, not one subject had a worsening of
inflammatory acne lesions during the two months, and all
had at least some reduction in inflammatory papules. The
average inflammatory lesion count at baseline was 20.8
and this decreased to 6.8 after two months. The average
lesion counts are presented in the bar graphs of figure 3.
One of the five subjects did have a higher overall acne
lesion count after two months, there was a specific 2-fold
increase in pustules and comedones, however, a 30 per-
cent reduction in inflammatory papules was also noted.
Based on the AIOS evaluations, the omega-3-based inter-
vention did seem to make a difference in mental outlook
and global aspects of well-being over two months. We
found an average 24 percent improvement in mental,
emotional, and social well-being among users of the
omega-3-poly-nutrient supplement. The positive changes
in aspects of well-being were evenly spread among the
group (range 20–27 percent) and did not appear to be
associated with acne lesions, nor were they restricted to
those who had the greatest reduction in acne lesions. The
results are in support of a growing body of research indi-
cating that the omega-3 fatty acid EPA can help regulate
Subject photo before use of omega-3 poly-nutrient capsules Figure 1
Subject photo before use of omega-3 poly-nutrient 
capsules
Subject photo after use of omega-3 poly-nutrient capsules Figure 2
Subject photo after use of omega-3 poly-nutrient 
capsulesLipids in Health and Disease 2008, 7:36 http://www.lipidworld.com/content/7/1/36
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mood and depressive symptoms, even in otherwise
healthy adults without clinical depression [47,48].
Our observations of these patients are only suggestive,
and they hint that omega-3 fatty acids, and perhaps other
nutrients in combination, may have a positive influence
on inflammatory acne lesions and aspects of mental
health. Obviously our decision to follow these individuals
may have had a profound influence on outcome. Acne is
a disease where the placebo effect has been well docu-
mented, and aspects of mental health are certainly influ-
enced by expectations and beliefs [49]. Awareness of our
interest in the outcome may have had an impact on the
expectations and beliefs pertaining to the product.
Although the subjects did not report changes in anti-acne
interventions, dietary changes, vitamins or herbal supple-
ment use, the effects of stress and environmental variables
cannot be discounted. Emotional stress has been known
to worsen acne, and this, combined with monthly hormo-
nal fluctuations, can influence both acne and mental
aspects of well-being [50].
Clearly, we can draw no conclusions from our observa-
tions in a select few cases of dietary supplement users. The
results in these cases should merely serve as a motivating
factor to pursue this line of research with more vigor, spe-
cifically in analyses which involve controls and determi-
nation of true statistical value. One clue that indicates the
results may be more than a placebo effect is the specific,
positive influence on inflammatory lesions, one that
occurred in conjunction with either no significant change
or even worsening of total non-inflammatory lesions. It is
also true that certain acne interventions such as isotretin-
oin, although clinically valuable, do not improve aspects
of mood, and may indeed make them worse [51]. The
rationale for a double-blind, placebo-controlled clinical
trial of EPA and/or anti-inflammatory nutrients in acne
and mental health is apparent. Objective measurements,
such as blood essential fatty acid levels, antioxidants and
sebum production, will lend scientific credibility to such
an investigation. The co-administration of EPA with
isotretinoin should also be considered. Given the great
degree of distress experienced by those with acne, any
intervention that has the potential to diminish the most
evident acne lesions, the inflammatory lesions, and
improve mental outlook, is certainly worth investigating.
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